QQ客服 官方微博 反馈留言

	Combined Evaluation of Expression of CXCR4 and Nrf2 as Prognostic Factor for Patients with Gastric Carcinoma
	Yu, Shuo; Wu, Tao; Wang, Jia; Cheng, Chuantao; Wang, Jing; Sun, Liangzhang; Liu, Chao; Cao, Gang; Hu, Tinghua
刊名	ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY
	2018
卷号	18页码:388-393
关键词	clinicopathological prognostic biomarker gastric carcinoma CXCR4 Nrf2
ISSN号	1871-5206
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2921254
专题	西安交通大学
推荐引用方式 GB/T 7714	Yu, Shuo,Wu, Tao,Wang, Jia,et al. Combined Evaluation of Expression of CXCR4 and Nrf2 as Prognostic Factor for Patients with Gastric Carcinoma[J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY,2018,18:388-393.
APA	Yu, Shuo.,Wu, Tao.,Wang, Jia.,Cheng, Chuantao.,Wang, Jing.,...&Hu, Tinghua.(2018).Combined Evaluation of Expression of CXCR4 and Nrf2 as Prognostic Factor for Patients with Gastric Carcinoma.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY,18,388-393.
MLA	Yu, Shuo,et al."Combined Evaluation of Expression of CXCR4 and Nrf2 as Prognostic Factor for Patients with Gastric Carcinoma".ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY 18(2018):388-393.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。